Erica D. Watson, Pharmd

Leveraged clinical knowledge, prescriptive authority, and innovative technology to strategically manage a diverse panel of 975+ patients across two states (LA & MS).

• Developed, implemented, and monitored guideline-based medication therapy plans to meet disease-specific goals and improve clinical outcomes. Overall, 88% of assigned patient panel achieved and maintained targeted A1C, and 70% of patients achieved targeted blood pressure goals.
• Evaluated medication adherence and delivered patient-centered consultative services to address healthcare barriers.
• Provided patients, caregivers, and healthcare professionals with accurate drug/disease state information and clinical resources.
• Cultivated and maintained strong relationships with specialists in endocrinology, cardiology, nephrology, and related fields to ensure continuity of care and increase engagement in Digital Medicine Programs.
• Co-chaired Quality Assurance Committee, actively driving the development and implementation of 10+ drug, disease-state, and workflow-specific protocols.

Completed postdoctoral pharmacy practice residency with concentrated focus in ambulatory care. Served as subject matter expert across various therapeutic areas within an interdisciplinary medical team in ambulatory care and acute care settings.

• Utilized collaborative practice agreement to provide medication therapy management for patients at a Federally Qualified Health Center.
• Led several patient advocacy initiatives, including launching a piloted MTM/Transitions of Care program for Medical Intensive Care Unit (MICU) patients at University Medical Center New Orleans.
• Managed aspects of the medication-use process related to formulary management by preparing drug class reviews, monographs, treatment guidelines, and protocols.

• Accurately interpreted and prepared new prescription orders.
• Educated patient disease state, prescription, and over-the-counter medications.
• Collaborated with providers, payors, and patients to resolve medication issues pertaining to drug interactions, drug-disease state interactions, duplicate therapy, and insurance prior authorizations.

• Served as USP Chapter 797 technician super-user, provided educational training on appropriate aseptic technique, and implemented universal hospital beyond-use date protocols for parenteral admixtures.